NCT05118334
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,258 public trials
1,193 recruiting studies
Carcinoma, Bronchogenic trial results
NCT02151604
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Oxford University Hospitals NHS Trust Oxford, England, United Kingdom
NCT01146756
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
NCT04059887
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Chonnam National University Hwasun Hospital Hwasun, Jeollanam-do, South Korea
NCT03512847
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Department of Oncology Næstved, Region Sjælland, Denmark
NCT05711914
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Jean-Paul BEREGI Nîmes, France
Completed
mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer
NCT03196986
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Cancer Institute/Hospital, Chinese Academy of Medical Sciences Beijing, China
- Peking University Shenzhen Hospital Shenzhen, China
Completed
Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases
NCT03463525
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Stockholm, Sweden
NCT02713529
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
- Locations
-
- Research Site Atlanta, Georgia, United States
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
- Research Site Grand Rapids, Michigan, United States
Completed
A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation
NCT01859026
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States